INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,038,421 | -16.7% | 635,185 | -30.4% | 0.29% | -11.4% |
| Q2 2023 | $19,245,373 | +23.8% | 912,103 | 0.0% | 0.32% | +14.0% |
| Q1 2023 | $15,551,356 | +11.4% | 912,103 | +30.6% | 0.28% | +3.6% |
| Q4 2022 | $13,954,292 | +424.4% | 698,413 | +232.6% | 0.28% | +84.6% |
| Q1 2016 | $2,661,000 | -30.2% | 210,000 | 0.0% | 0.15% | -22.0% |
| Q4 2015 | $3,812,000 | +42.0% | 210,000 | +45.2% | 0.19% | +22.4% |
| Q3 2015 | $2,685,000 | +24.1% | 144,600 | +63.2% | 0.16% | +33.3% |
| Q2 2015 | $2,164,000 | +17.4% | 88,600 | 0.0% | 0.12% | -15.8% |
| Q1 2015 | $1,843,000 | +34.4% | 88,600 | 0.0% | 0.14% | -7.3% |
| Q4 2014 | $1,371,000 | +18.6% | 88,600 | 0.0% | 0.15% | -6.8% |
| Q3 2014 | $1,156,000 | -34.7% | 88,600 | 0.0% | 0.16% | -33.2% |
| Q2 2014 | $1,770,000 | +29.1% | 88,600 | +23.1% | 0.24% | +13.1% |
| Q1 2014 | $1,371,000 | +144.8% | 72,000 | +118.8% | 0.21% | +23.1% |
| Q4 2013 | $560,000 | – | 32,900 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |